IP Library Assignment 055334/0754
Patent Assignment
Reel/Frame 055334/0754

Change of Name

Recorded: 2021-02-18 Pages: 4
Assignor
SEATTLE GENETICS, INC.
Executed: 2020-10-06
Assignee
SEAGEN INC.
21823 30TH DRIVE SE, BOTHELL, WASHINGTON, 98021
Covered Properties (34)
Auristatins Having an Aminobenzoic Acid Unit at the N Terminus
Patent: 8,288,352 →
Application: 11/667,437 →
Publication: US US20080300192A1
Monomethylvaline Compounds Having Phenylalanine Side-Chain Replacements at the C-Terminus
Patent: 8,343,928 →
Application: 11/994,809 →
Publication: US 2009/0018086
Monomethylvaline Compounds Having Phenylalanine Side-Chain Modifications at the C-Terminus
Application: 13/666,766 →
Publication: US 2013/0123465
Monomethylvaline Compounds Having Phenylalanine Carboxy Modifications at the C-Terminus
Patent: 8,871,720 →
Application: 11/994,459 →
Publication: US US20090111756A1
Methods of Using Monomethylvaline Compositions Having Phenylalanine Carboxy Modifications at the C-Terminus
Patent: 9,522,194 →
Application: 14/502,210 →
Publication: US US20150044238A1
Antibody Drug Conjugate Metabolites
Patent: 7,750,116 →
Application: 11/677,029 →
Bio Cell Cleaning Centrifuge and Bio Cell Cleaning Rotor Used in the Same
Patent: 8,152,707 →
Application: 12/142,422 →
Publication: US US20080318755A1
Auristatin Drug Linker Conjugates
Patent: 8,609,105 →
Application: 12/933,364 →
Publication: US US20110020343A1
Auristatin Drug Linker Conjugates
Patent: 9,463,252 →
Application: 14/061,261 →
Publication: US US20140050746A1
Synergistic Effects Between Auristatin-Based Antibody Drug Conjugates and Inhibitors of the PI3K-Akt Mtor Pathway
Patent: 9,272,052 →
Application: 13/879,012 →
Publication: US US20130209496A1
Synergistic Effects Between Auristatin-Based Antibody Drug Conjugates and Inhibitors of the PI3K-Akt Mtor Pathway
Application: 15/008,365 →
Publication: US US20160220693A1
P-Amidobenzylethers in Drug Delivery Agents
Patent: 7,091,186 →
Application: 09/963,103 →
Publication: US US20030096743A1
P-Amidobenzylethers in Drug Delivery Agents
Patent: 7,553,816 →
Application: 10/252,947 →
Publication: US US20030130189A1
Heterocyclic Self-Immolative Linkers and Conjugates
Patent: 7,375,078 →
Application: 11/064,785 →
Publication: US US20050256030A1
Heterocyclic Self-Immolative Linkers and Conjugates
Patent: 7,754,681 →
Application: 11/925,659 →
Publication: US US20090041791A1
Heterocyclic Self-Immolative Linkers and Conjugates
Patent: 7,989,434 →
Application: 12/764,821 →
Publication: US US20100273843A1
Partially Loaded Antibodies and Methods of Their Conjugation
Patent: 7,837,980 →
Application: 10/591,743 →
Publication: US US20090010945A1
Beta-Glucuronide-Linker Drug Conjugates
Patent: 8,039,273 →
Application: 11/996,009 →
Publication: US US20080241128A1
Beta-Glucuronide-Linker Drug Conjugates
Patent: 45,272 →
Application: 14/056,145 →
Beta-Glucuronide-Linker Drug Conjugates
Patent: 8,568,728 →
Application: 13/274,212 →
Publication: US US20120107332A1
Beta-Glucuronide-Linker Drug Conjugates
Patent: 9,731,030 →
Application: 14/036,968 →
Publication: US US20170189540A9
Methods for Screening Antibodies
Patent: 9,725,500 →
Application: 13/581,236 →
Publication: US US20120322686A1
Intact Mass Determination of Protein Conjugated Agent Compounds
Patent: 9,958,455 →
Application: 14/346,670 →
Publication: US US20140242624A1
Self-Stabilizing Linker Conjugates
Patent: 9,504,756 →
Application: 13/799,244 →
Publication: US US20130309256A1
Variant Target Binding Agents and Uses Thereof
Patent: 8,455,622 →
Application: 12/516,914 →
Publication: US US20100158909A1
Variant Target Binding Agents and Uses Thereof
Patent: 9,061,074 →
Application: 13/826,260 →
Publication: US US20140105922A1
Variant Target Binding Agents and Uses Thereof
Application: 15/189,216 →
Publication: US US20160367697A1
Methods and Compositions for Making Antibodies and Antibody Derivatives with Reduced Core Fucosylation
Patent: 8,163,551 →
Application: 12/434,533 →
Publication: US US20090317869A1
Methods and Compositions for Making Antibodies and Antibody Derivatives with Reduced Core Fucosylation
Patent: 8,574,907 →
Application: 13/405,143 →
Publication: US US20120183997A1
Methods and Compositions for Making Antibodies and Antibody Derivatives with Reduced Core Fucosylation
Patent: 8,993,326 →
Application: 14/043,742 →
Publication: US US20140031536A1
Methods and Compositions for Making Antibodies and Antibody Derivatives with Reduced Core Fucosylation
Patent: 9,816,069 →
Application: 14/632,925 →
Publication: US US20150337259A1
Methods and Compositions for Making Antibodies and Antibody Derivatives with Reduced Core Fucosylation
Application: 15/729,258 →
Publication: US US20180155677A1
Methods of Inhibition of Protein Fucosylation in Vivo Using Fucose Analogs
Patent: 9,504,702 →
Application: 13/814,083 →
Publication: US US20130129784A1
Methods of Inhibition of Protein Fucosylation in Vivo Using Fucose Analogs
Application: 15/299,894 →
Publication: US US20170035790A1
Related Assignments (14)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 15, 2002
From: SENTER, PETER D.; TOKI, BRIAN E.
To: SEATTLE GENETICS, INC.
Reel/Frame 012717/0376 →
Assignment of Assignor's Interest Jan 6, 2003
From: SENTER, PETER D.; TOKI, BRIAN E.
To: SEATTLE GENETICS, INC.
Reel/Frame 013643/0424 →
Assignment of Assignor's Interest Jul 18, 2005
From: FENG, BAINIAN
To: GENETECH, INC.
Reel/Frame 016792/0910 →
Assignment of Assignor's Interest Apr 17, 2007
From: JEFFREY, SCOTT
To: SEATTLE GENETICS, INC.
Reel/Frame 019174/0060 →
Assignment of Assignor's Interest May 23, 2007
From: DORONINA, SVETLANA O.; CERVENY, CHARLES G.; WAHL, ALAN F.
To: SEATTLE GENETICS
Reel/Frame 019334/0936 →
Assignment of Assignor's Interest Jul 10, 2007
From: DORONINA, SVETLANA O.; CERVENY, CHARLES G.; WAHL, ALAN F.
To: SEATTLE GENETICS, INC.
Reel/Frame 019537/0322 →
Assignment of Assignor's Interest Mar 5, 2008
From: DORONINA, SVETLANA O.; MENDELSOHN, BRIAN A.
To: SEATTLE GENETICS, INC.
Reel/Frame 020605/0425 →
Assignment of Assignor's Interest Mar 18, 2008
From: GENENTECH, INC.
To: SEATTLE GENETICS, INC.
Reel/Frame 020668/0359 →
Assignment of Assignor's Interest Jul 1, 2009
From: GENENTECH, INC.
To: SEATTLE GENETICS, INC.
Reel/Frame 022899/0339 →
Assignment of Assignor's Interest Sep 14, 2009
From: YAMADA, KENJI
To: HITACHI KOKI CO., LTD.
Reel/Frame 023224/0993 →
Assignment of Assignor's Interest May 13, 2010
From: ALLEY, STEPHEN C.
To: SEATTLE GENETICS, INC.
Reel/Frame 024379/0045 →
Assignment of Assignor's Interest Jul 16, 2010
From: GENENTECH, INC.
To: SEATTLE GENETICS, INC.
Reel/Frame 024700/0429 →
Assignment of Assignor's Interest May 2, 2013
From: LEWIS, TIMOTHY S.; LAW, CHE-LEUNG; MCEARCHERN, JULIE A.
To: SEATTLE GENETICS, INC.
Reel/Frame 030334/0694 →
Assignment of Assignor's Interest Dec 16, 2019
From: DORONINA, SVETLANA O.; KLINE, TONI BETH
To: SEATTLE GENETICS INC.
Reel/Frame 051290/0624 →